Literature DB >> 18365855

Use of complementary medicinal therapies in West Pomerania: a population-based study.

S Schwarz1, H Messerschmidt, H Völzke, W Hoffmann, M Lucht, M Dören.   

Abstract

OBJECTIVES: Prior studies suggested a high prevalence of complementary and alternative medicine (CAM) in Germany. The objectives of this study were (1) to describe in more detail the utilization of CAM, (2) to compare characteristics between CAM users and non-users, and (3) to delineate information on source of prescription and insurance coverage of 14 specific CAM therapies.
METHODS: We extracted information derived from a computer-aided personal interview on the use of CAM, medical history, behavioral, and sociodemographic characteristics, all of which were generated by the Study of Health in Pomerania (formerly part of East Germany), a cross-sectional population-based survey. We analyzed data from 4291 individuals aged 20-79 years.
RESULTS: Use of any CAM within the previous year was reported by 6.0% of the population. The modality used most widely among CAM users was active and passive exercise therapy (including various massage therapies). CAM users, when compared to non-users, were more likely to be female, experienced more years of education, were more physically active, less often overweight, reported a lower self-rated physical health status, and were more likely to visit an outpatient facility during the last year. There were higher proportions of several chronic diseases in CAM users than non-users. The results of this survey suggest that CAM therapies were most often utilized to alleviate pain. Most CAM therapies were prescribed by a physician. Reimbursement schemes were complex and differed according to therapy.
CONCLUSIONS: The low estimate of CAM use might be explained by specific characteristics of the study region, including changes after the German reunification. CAM users and non-users differ with respect to several behavioral, sociodemographic and medical characteristics.

Entities:  

Mesh:

Year:  2008        PMID: 18365855     DOI: 10.1080/13697130801930674

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  6 in total

1.  Use of complementary and alternative medicine by those with a chronic disease and the general population--results of a national population based survey.

Authors:  Amy Metcalfe; Jeanne Williams; Jane McChesney; Scott B Patten; Nathalie Jetté
Journal:  BMC Complement Altern Med       Date:  2010-10-18       Impact factor: 3.659

2.  The use of complementary and alternative medicine products in preceding two days among Finnish parents - a population survey.

Authors:  Katri P Hämeen-Anttila; Ulla R Niskala; Sanna M Siponen; Riitta S Ahonen
Journal:  BMC Complement Altern Med       Date:  2011-11-04       Impact factor: 3.659

3.  Intervention development for integration of conventional tobacco cessation interventions into routine CAM practice.

Authors:  Myra L Muramoto; Eva Matthews; Cheryl K Ritenbaugh; Mark A Nichter
Journal:  BMC Complement Altern Med       Date:  2015-03-29       Impact factor: 3.659

4.  Complementary and alternative medicine (CAM) as part of primary health care in Germany-comparison of patients consulting general practitioners and CAM practitioners: a cross-sectional study.

Authors:  Katja Krug; Katharina I Kraus; Kathrin Herrmann; Stefanie Joos
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

Review 5.  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.

Authors:  Peter J H Beliveau; Jessica J Wong; Deborah A Sutton; Nir Ben Simon; André E Bussières; Silvano A Mior; Simon D French
Journal:  Chiropr Man Therap       Date:  2017-11-22

6.  Age, chronic non-communicable disease and choice of traditional Chinese and western medicine outpatient services in a Chinese population.

Authors:  Vincent Ch Chung; Chun Hong Lau; Eng Kiong Yeoh; Sian Meryl Griffiths
Journal:  BMC Health Serv Res       Date:  2009-11-17       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.